Core Viewpoint - The announcement from Kanghui Pharmaceutical indicates that a major shareholder, Chuangxiangying, has pledged 1.9976 million shares, which represents 33.33% of its holdings and 2% of the company's total share capital. The purpose of the pledge is to supplement working capital [1] Summary by Categories Shareholder Pledge - Chuangxiangying has pledged a total of 1.9976 million shares, accounting for 33.33% of its holdings and 2% of the total share capital of the company [1] - As of the announcement date, Chuangxiangying has cumulatively pledged 3.9952 million shares, which is 66.67% of its holdings and 4% of the company's total share capital [1] Financing Purpose - The funds raised from the share pledge will be used to supplement the company's working capital [1]
康惠制药:股东创响盈质押199.76万股